文献速递神经重症与神经感染

脑MRI与眼科生物标志物预测颅内高压

Brain MRI and Ophthalmic Biomarkers of Intracranial Pressure.
PubMed 文献 · Neurology · 2021-05-31

本研究在45例患者中评估6种脑MRI和眼科生物标志物与24小时颅内压监测结果的关联。所有6种标志物均与24小时颅内压显著相关,≥3个异常标志物或MRI与眼科联合异常高度提示颅内高压。

要点

  • 6种生物标志物均与24小时颅内压显著相关。
  • ≥3个异常标志物患者均存在颅内高压。
  • MRI与眼科联合异常对颅内高压的AUC为0.94。

核心结论

  • 脑MRI和眼科生物标志物可无创指导疑似脑脊液动力学异常患者的管理。
  • 多个异常标志物(≥3个)或MRI与眼科联合异常提示颅内高压,应及时处理。

研究设计与样本

  • 单中心观察性研究,纳入45例接受24小时颅内压监测、脑MRI(3个月内)和眼科评估(监测期间)的患者。

主要发现

  • 45例患者平均年龄39±14岁,38例女性。
  • 所有6种生物标志物均与24小时颅内压显著相关。
  • 所有标志物正常者中94%(标准误6%)中位颅内压正常。
  • ≥3个异常标志物患者均存在颅内高压。

关键数值与推荐

  • 颅内压升高定义为24小时中位颅内压>5.96 mm Hg(切值通过Youden指数计算)。
  • 研究评估的6种生物标志物:垂体形态、视神经垂直迂曲、视神经鞘扩张、视盘突出(MRI)、视乳头水肿(裂隙灯生物显微镜)、自发性静脉搏动(红外视频记录)。

临床怎么用

  • 对于疑似脑脊液动力学异常患者,可结合脑MRI和眼科生物标志物无创评估颅内高压风险。
  • 发现≥3个异常标志物或MRI与眼科联合异常时,应警惕颅内高压并及时管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the utility of brain MRI and ophthalmic biomarkers for the prediction of intracranial hypertension, we have studied the association between 6 biomarkers and 24-hour intracranial pressure (ICP) monitoring results in 45 patients. METHODS: This single-center observational study includes patients who underwent 24-hour ICP monitoring, brain MRI (within 3 months), and ophthalmic assessment (during ICP monitoring). Six biomarkers were investigated: pituitary gland shape, vertical tortuosity of the optic nerve, distension of the optic nerve sheath, optic disc protrusion (MRI), papilledema (slit lamp biomicroscopy), and spontaneous venous pulsations (SVP, infrared video recordings). RESULTS: Forty-five patients (mean age 39 ± 14 years, 38 women) met the inclusion criteria. All 6 biomarkers had a significant association with 24-hour ICP. Concave pituitary gland was observed with moderately elevated median ICP. Protrusion of the optic disc (MRI), papilledema, and absence of SVP were associated with the highest median ICP values. Twenty patients had raised ICP (median 24-hour ICP >5.96 mm Hg, cutoff obtained through Youden index calculation). Patients with all normal biomarkers had normal median ICP in 94% (standard error 6%) of the cases. All patients with ≥3 abnormal biomarkers had intracranial hypertension. The combination of at least 1 abnormal biomarker in MRI and ophthalmic assessments was highly suggestive of intracranial hypertension (area under the curve 0.94, 95% confidence interval 0.93-0.94) CONCLUSIONS: Brain MRI and ophthalmic biomarkers can noninvasively guide the management of patients with suspected CSF dynamics abnormalities. Patients with multiple abnormal biomarkers (≥3) or a combination of abnormal MRI and ophthalmic biomarkers are likely to have intracranial hypertension and should be managed promptly.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. D'Antona L, Asif H, Craven CL, et al. Brain MRI and Ophthalmic Biomarkers of Intracranial Pressure. Neurology. 2021. PMID: 33849988. doi:10.1212/WNL.0000000000012023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。